These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 24497981)
1. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis. Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981 [TBL] [Abstract][Full Text] [Related]
2. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects. Xia S; Wu S; Wang M Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875 [TBL] [Abstract][Full Text] [Related]
3. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects. Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310 [TBL] [Abstract][Full Text] [Related]
4. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis. Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722 [TBL] [Abstract][Full Text] [Related]
5. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis. Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562 [TBL] [Abstract][Full Text] [Related]
6. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population. Kumar A; Pant MC; Singh HS; Khandelwal S Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240 [TBL] [Abstract][Full Text] [Related]
7. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis. Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084 [TBL] [Abstract][Full Text] [Related]
8. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis. Li Y; Liu F; Tan SQ; Wang Y; Li SW PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511 [TBL] [Abstract][Full Text] [Related]
9. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237 [TBL] [Abstract][Full Text] [Related]
10. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis. Zhang H; Liu H; Knauss JL Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607 [TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies. Zhang XQ; Li L Medicine (Baltimore); 2021 Dec; 100(50):e28030. PubMed ID: 34918657 [TBL] [Abstract][Full Text] [Related]
12. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis. Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969 [TBL] [Abstract][Full Text] [Related]
13. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects. Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984 [TBL] [Abstract][Full Text] [Related]
14. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis. Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881 [TBL] [Abstract][Full Text] [Related]
15. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision. Zhao DY; Cheng L; Yu J; Shen H Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies. Zhang H; Liu H; Jiang G PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792 [TBL] [Abstract][Full Text] [Related]
17. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. Xie T; Wang ZG; Zhang JL; Liu H World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255 [TBL] [Abstract][Full Text] [Related]
18. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis. Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739 [TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer. Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046 [TBL] [Abstract][Full Text] [Related]
20. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis. Li C; Xiang X; Zhou Y Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]